首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 171 毫秒
1.
虫草多糖对8-MOP/UVA诱导皮肤成纤维细胞光老化的拮抗作用   总被引:1,自引:0,他引:1  
目的探讨虫草多糖(Cordyceps Polysaccharides,CP)对皮肤成纤维细胞光老化的保护作用。方法用8-甲氧补骨脂素联合UVA(8-MOP/UVA)诱导皮肤成纤维细胞光老化,用HE染色、MTT、羟脯氨酸含量、丙二醛含量检测及SOD活力分析等方法观察虫草多糖对成纤维细胞光老化过程中的形态、活力、胶原合成及抗氧化能力的影响。结果光老化组细胞发生形态改变,增殖能力明显下降,羟脯氨酸含量下降,丙二醛含量升高,SOD活力下降,虫草保护组细胞有所改善。结论虫草多糖对8-MOP/UVA诱导皮肤成纤维细胞光老化有拮抗作用。  相似文献   

2.
虫草多糖对小鼠皮肤光老化的保护作用   总被引:3,自引:0,他引:3  
目的探讨冬虫夏草多糖对小鼠皮肤光老化的保护作用。方法用8-甲氧补骨脂素(8-MOP)联合UVA制备小鼠皮肤光老化模型,在造模前给皮肤涂抹虫草多糖溶液,造模后24 h内取皮肤组织,进行HE染色和电镜观察并检测组织羟脯氨酸含量。结果光老化组皮肤真皮层明显增厚,炎细胞浸润,皮脂腺不规则增生,纤维组织疏松紊乱,常见断裂,成纤维细胞形态不规则,内质网少,虫草多糖保护组明显改善,羟脯氨酸含量较光老化组明显增加。结论虫草多糖对皮肤光老化具有保护作用。  相似文献   

3.
目的研究代代花中总黄酮含量,以及使用细胞及非细胞方法检测其抗氧化活性。方法利用水提醇沉方法提取代代花中总黄酮,HPLC方法测定黄酮含量,并对代代花提取物的总抗氧化能力(ABTS)、清除羟自由基能力进行研究,及由紫外线(UVB)引起的上皮细胞、皮肤成纤维细胞的活性氧(ROS)水平的影响。结果代代花提取物主要成分为柚皮苷和新橙皮苷,具有好的抗氧化作用,并能降低UVB引起的皮肤细胞内的ROS水平。结论代代花黄酮提取简便且功能较强,可以应用于抗氧化的化妆品或保健品中。  相似文献   

4.
目的 探讨刺五加多糖对氧糖剥夺诱导神经元氧化损伤的保护作用.方法 培养PC12细胞,采用氧糖剥夺(OGD)及厌氧袋相结合法建立缺血诱导神经细胞继发损伤模型,电镜观察细胞形态,应用比色法测定细胞外液中乳酸脱氢酶(LDH)活力、MDA含量和SOD酶活力.结果 与模型组比较,刺五加多糖干预后PC12细胞氧化损伤明显减轻,细胞SOD酶活力提高,细胞内MDA含量及LDH释放量降低.结论 刺五加多糖对OGD引起的神经元样细胞的损伤具有保护作用,其作用机制可能与刺五加多糖具有抗氧化、清除自由基的作用有关.  相似文献   

5.
目的探讨十全大补汤调整肉桂剂量对氧化损伤大鼠真皮成纤维细胞内活性氧水平和线粒体膜电位的影响。方法原代培养成纤维细胞,用H2O2造成氧化损伤成纤维细胞模型,以血清药理学方法获取含不同剂量肉桂的十全大补汤大鼠血清,用含药血清对成纤维细胞模型进行干预。运用流式细胞术结合DCFH—DA、JC-1探针方法检测成纤维细胞胞内活性氧和线粒体膜电位。结果含不同剂量肉桂的十全大补汤均具有良好的清除活性氧作用,组间差异无统计学意义(P〉0.05)。2倍肉桂组阻滞线粒体膜电位下降明显,差异有统计学意义(P〈0.01)。结论不同肉桂剂量十全大补汤可清除氧化损伤的大鼠真皮成纤维细胞胞内活性氧,2倍肉桂剂量可起到抑制细胞凋亡的作用。  相似文献   

6.
红芪总多糖诱导S180瘤细胞凋亡的实验研究   总被引:3,自引:0,他引:3  
目的:研究红芪总多糖(THPS)诱导小鼠S180瘤细胞凋亡作用及其机制。方法:昆明小鼠60只接种S180瘤后随机分为5组。(1)模型组(S):生理盐水腹腔注射,(2)环磷酰胺组(CY):CY腹腔注射,(3)THPS低剂量(H100),(4)THPS中剂量(H200)和(5)THPS高剂量组(H400):分别给予THPS低剂量、中剂量和高剂量腹腔注射,14 d后处死小鼠。电镜观察各组瘤细胞的形态,激光共聚焦(LSCM)测定每组瘤细胞DNA、RNA含量、细胞内钙离子浓度、自由基含量及线粒体膜电位。结果:中剂量的THPS可明显升高细胞内钙离子浓度、自由基含量及降低线粒体膜电位和瘤细胞DNARNA含量的作用。结论:THPS中剂量通过升高细胞内钙离子浓度、自由基含量及降低线粒体膜电位诱导小鼠S180瘤细胞凋亡。  相似文献   

7.
目的:探讨黄芪多糖对缺血再灌注损伤脐静脉内皮细胞氧化应激的影响。方法:将培养至5代的脐静脉内皮细胞随机分为正常对照组、模型组、模型+黄芪多糖组、模型+美托洛尔组,观察黄芪多糖对缺血再灌注损伤脐静脉内皮细胞活性、ROS、LDH、MDA含量、线粒体膜电位的影响。结果:与正常对照组比较,缺血再灌注损伤脐静脉内皮细胞ROS、MDA含量、LDH漏出率均显著升高,线粒体膜电位、细胞活性下降;黄芪多糖干预后,缺血再灌注损伤脐静脉内皮细胞ROS、MDA含量、LDH漏出率降低,线粒体膜电位、细胞活性升高。结论:黄芪多糖可能通过抑制自由基、脂质过氧化产物的生成,减少氧化应激而保护缺血再灌注损伤内皮细胞。  相似文献   

8.
目的:观察姬松茸多糖对地塞米松(dexamethasone,DEX)诱发大鼠胸腺细胞凋亡和线粒体膜电位的影响.方法:Wistar大鼠随机分为4组:正常组,模型组,姬松茸多糖低、高剂量组,每组10只.正常组和模型组灌胃(ig)生理盐水,姬 松茸多糖低、高剂量组ig姬松茸多糖溶液(60,120 mg·kg-1),1次/d,连续7d.模型组和姬松茸多糖低、高剂量于第7日腹腔注射DEX(0.02 g·kg-1).3h后处死各组动物,迅速无菌取胸腺,采用显微观察、流式细胞技术观察胸腺细胞形态学改变,胸腺细胞凋亡、脱氧核糖核酸(DNA)断裂百分率及线粒体膜电位变化,胸腺组织超氧化物歧化酶(SOD)、丙二醛(MDA)的变化.结果:与模型组比较,姬松茸多糖组大鼠胸腺细胞线粒体嵴肿胀明显减轻;姬松茸多糖组大鼠胸腺细胞凋亡率[低、高剂量(5.96±1.14)%,(5.07±1.02)%],DNA断裂率[低、高剂量(3.67±0.49)%,(3.24±0.45)%]及胸腺组织MDA含量[低、高剂量(1.87±0.25),(1.72±0.23)μg·mg-1]均明显低于模型组[(7.14±1.62)%,(4.25±0.86)%,(2.16±0.38) μg·mg-1];姬松茸多糖组大鼠胸腺细胞线粒体膜电位(荧光指数:低剂量38.57±6.29,高剂量41.36±7.18)及胸腺组织SOD活性量[低、高剂量(25.78±3.94),(27.36 ±4.21)U.mg-1]明显高于模型组(32.76 ±5.48)荧光指数,(21.45±3.52) i g· mg-1.结论:姬松茸多糖可阻断胸腺细胞DNA断裂和线粒体膜电位的下降,有效抑制DEX诱导的胸腺细胞凋亡,其作用机制与姬松茸多糖提高胸腺组织抗氧化功能有关.  相似文献   

9.
目的:研究四逆汤(Sini decoction,SND)对脓毒症模型大鼠心肌细胞线粒体损伤的保护机理。方法:将70只大鼠随机分为正常对照组10只,模型组和四逆汤组各30只,(1、3、5 d各10只),通过失血以及静脉注射脂多糖2次打击以建立脓毒症大鼠模型。四逆汤组在二次打击后给予四逆汤灌胃,1次/d;模型组按相同溶液体质量剂量、时点灌蒸馏水。在模型建立后的1、3、5 d分别处死大鼠,采血行心脏有关酶学CK、CK-MB检测;分离心肌细胞线粒体,行线粒体肿胀度、膜电位及总ATP酶、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)检测;电镜观察心肌细胞线粒体形态学变化。结果:与正常对照组比较,模型组CK、CK-MB及线粒体肿胀度显著升高(P0.01),1 d时出现峰值,而治疗组较模型组有显著改善(P0.01)。模型组的线粒体膜电位、总ATP酶、SOD及GSH值与正常对照组比较显著降低(P0.01),而治疗组较模型组显著(P0.05或P0.01)。电镜观察脓毒症模型组线粒体结构破坏明显,出现空泡化,而治疗组较模型组减轻。结论:四逆汤能有效保护脓毒症心肌细胞线粒体功能,其机制可能与提高线粒体的抗氧化能力、减少氧化损伤、改善线粒体的呼吸功能有关。  相似文献   

10.
目的:评价浙贝母多糖的体外抗氧化能力。方法:以热水回流提取法(料液比1∶10,100℃下提取4h)从浙贝母(Fritillaria thunbergii Miq.)鳞茎提取的多糖为材料,通过清除1,1-二苯基-2-苦肼基自由基(DPPH)、还原能力和总抗氧化能力等体外抗氧化实验来评价浙贝母多糖的体外抗氧化能力。结果:浙贝母多糖清除DPPH自由基能力不明显,而还原能力和清除羟基自由基能力均随多糖浓度的增加而上升;1 mg·mL-1的多糖对DPPH自由基的清除率为21.46%,还原能力和总抗氧化活性1 mg·mL-1多糖在695 nm下吸光值分别为0.51和0.39。结论:浙贝母多糖有较强的抗氧化能力,对体外自由基有较好的清除作用。  相似文献   

11.
目的:观察针刺对光老化模型小鼠皮肤的影响,探讨针刺的抗皮肤光老化作用及其机制。方法:昆明种小鼠40只,随机分为空白组、模型组、针刺组、阳性对照组(维生素E组)4组10只。除正常对照组外,其余各组均每日用1%甲氧沙林溶液(8-MOP)联合长波紫外线(UVA)制备小鼠皮肤光老化模型。造模前针刺组针刺“足三里”“关元”穴,阳性对照组采用VE涂抹造模部位,造模后24 h内取皮肤组织。观察小鼠皮肤组织超氧化物歧化酶(SOD)、丙二醛(MDA)、总抗氧化能力(T-AOC)、ATP酶活性及和脂褐素(LF)水平。结果:SOD、T-AOC及ATP酶活性升高,MDA、LF含量降低。结论:针刺可通过提高光老化皮肤抗氧化物酶活性,改变氧化产物含量,从而达到抗皮肤光老化作用。  相似文献   

12.
[目的]观测绞股蓝对小鼠皮肤光老化保护作用。[方法]将昆明种小鼠60只随机分为空白组、模型组、阳性对照组(维生素E组)、绞股蓝低、中、高剂量组,10只/组。除正常对照组外,各组均每日用8-甲氧补骨脂素(8-MOP)联合UVA建立小鼠皮肤光老化模型,造模前给予皮肤分别涂抹维生素E、绞股蓝提取液,造模后24 h内取皮肤组织。观测组织谷胱甘肽过氧化物酶(GSH-Px)、过氧化氢酶(CAT)、氧化产物过氧化氢(H2O2)、皮肤组织羟脯氨酸(HYP)。[结果]绞股蓝可提高光老化模型小鼠皮肤组织GSH-Px和CAT活性和HYP含量,降低H2O2含量。[结论]绞股蓝对皮肤光老化具有保护作用。  相似文献   

13.
冬虫夏草和青蒿素抑制狼疮性肾炎复发的研究   总被引:35,自引:0,他引:35       下载免费PDF全文
目的:观察冬虫夏草(简称虫草)和青蒿素抑制狼疮性肾炎复发的作用。方法:61例经用激素及环磷酰胺冲击治疗已无狼疮活动的狼疮性肾炎患者,随机分为两组,治疗组(31例)予虫草粉每日3-4g,分3次空腹口服;青蒿素粉每日0.6g,分3次餐后口服,连续服用3年。对照组(30例)口服雷公藤多甙片(或)保肾康片等药物治疗。两组均连续观察5年,监测血肌酐、肌酐清除率、抗核抗体等实验室有关指标及有否狼疮活动的临床表现。结果:治疗组显效26例(83.9%),有效4例(12.9%),无效1例(3.2%);对照组显效15例(50.0%),有效8例(26.7%),无效7例(23.3%),两组显效率比较差异有显著性(P<0.01)。治疗组补体C3持续稳定在(1.21±0.20)g/L正常水平,肌酐清除率治疗前后比较差异无显著性,与对照组比较差异有显著性;治疗组同时减少了药物本身的不良反应。结论:冬虫夏草和青蒿素可以抑制狼疮肾炎的复发,保护肾功能。  相似文献   

14.
 目的 探讨长波紫外线( UVA )对人皮肤成纤维细胞增殖及诱导型一氧化氮合酶( inducible nitric oxide synthase , iNOS )表达的影响,探讨白藜芦醇对此影响的防护作用及其机制。 方法 5 J·cm-2 UVA 照射原代培养的成纤维细胞后予以 0.01 , 0.1 mmol·L-1 浓度的白藜芦醇干预,四甲基偶氮唑盐 (MTT) 法检测细胞增殖活性,半定量逆转录聚合酶链反应( RT-PCR )和蛋白质印迹( Western-blot )方法检测细胞 iNOS mRNA 和蛋白的表达。 结果 UVA 辐射后成纤维细胞的增殖活性( 0.345 ± 0.020 )较正常对照组( 0.581 ± 0.038 )降低, iNOS mRNA/ 蛋白的表达水平[( 0.834 ± 0.087 ) / ( 0.804 ± 0.021 )]较正常对照组 ( 未见表达 ) 显著增加。 UVA 辐射后立即予以 0.01 或 0.1 mmol·L-1 浓度的白藜芦醇处理发现成纤维细胞的增殖活性上升而 iNOS mRNA/ 蛋白的表达下调,与单独 UVA 辐射组相比,差异有统计学意义 (<>P<0.05) 。 结论 UVA 可抑制体外培养的真皮成纤维细胞的增殖,诱导 iNOS 的表达,而白藜芦醇对 UVA 辐射损伤的成纤维细胞有保护作用。  相似文献   

15.
Oxidative damage of biomolecules increases with age and is postulated to be a major causal factor of various physiological function disorders. Consequently, the concept of anti-age by antioxidants has been developed. Lycium barbarum fruits have been used as a traditional Chinese herbal medicine and the data obtained in in vitro models have clearly established the antioxidant potency of the polysaccharides isolated from the fruits. In the present study, the age-dependent changes in the antioxidant enzyme activity, immune function and lipid peroxidation product were investigated and effect of Lycium barbarum polysaccharides on age-induced oxidative stress in different organs of aged mice was checked. Lycium barbarum polysaccharides (200, 350 and 500 mg/kg b.w. in physiological saline) were orally administrated to aged mice over a period of 30 days. Aged mice receiving vitamin C served as positive control. Enzymatic and non-enzymatic antioxidants, lipid peroxides in serum and tested organs, and immune function were measured. Result showed that increased endogenous lipid peroxidation, and decreased antioxidant activities, as assessed by superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and total antioxidant capacity (TAOC), and immune function were observed in aged mice and restored to normal levels in the polysaccharides-treated groups. Antioxidant activities of Lycium barbarum polysaccharides can be compable with normal antioxidant, vitamin C. Moreover, addition of vitamin C to the polysaccharides further increased the in vivo antioxidant activity of the latter. It is concluded that the Lycium barbarum polysaccharides can be used in compensating the decline in TAOC, immune function and the activities of antioxidant enzymes and thereby reduces the risks of lipid peroxidation accelerated by age-induced free radical.  相似文献   

16.
Our previous study demonstrated that the fruiting bodies of Cordyceps sinensis, a traditional Chinese medicine, attenuated diabetes-induced weight loss, polydipsia, and hyperglycemia in rats. In the present study, we further compared the anti-hyperglycemic activity of the fermented mycelia and broth of Cordyceps sinensis with that of the fruiting bodies. Male Wistar rats orally administered a placebo (STZ group), fruiting bodies (FB group, 1 g/day), fermented mycelia (MCS group, 1 g/day), fermented broth (BCS group, 1 g/day), or fermented mycelia plus broth (XCS group, 0.5 g/day of each) of Cordyceps sinensis (d1 to d28) were injected with nicotinamide (200 mg/kg) and streptozotocin (65 mg/kg) on d15. Rats fed with a placebo and injected with saline served as the control (CON) group. The amount of water and food consumption (d15 to d29), the 2-hour-postprandial blood glucose concentrations (d21 and d28), and the serum concentrations of fructosamine (d29) were significantly lower in the FB, MCS, BCS, and XCS groups than in the STZ group (one-way ANOVA, p < 0.05). The diabetic rats had significantly higher blood glucose concentrations as measured by the oral glucose tolerance test than the control rats; moreover, these changes were significantly reduced by ingesting the fruiting bodies, fermented mycelia and/or broth of Cordyceps sinensis. Our results revealed that the fermented mycelia and broth of Cordyceps sinensis have anti-hyperglycemic activities similar to those of the fruiting bodies. Therefore, the fermented products of Cordyceps sinensis could be developed as potential anti-diabetic agents or functional foods for persons with a high risk of diabetes mellitus.  相似文献   

17.
This study aimed to elucidate pharmacological activities of Cordyceps militaris. The 70% ethanolic extracts of cultured mycelia (CME) and fruiting bodies (FBE) of Cordyceps militaris were prepared. CME was able to directly scavenge the stable free radical diphenyl-2-picrylhydrazyl (DPPH), indicating its antioxidant activity. Both CME and FBE showed topical anti-inflammatory activity in the croton oil-induced ear edema in mice. CME was found to contain acute anti-inflammatory activity, which was evaluated using the carrageenin-induced edema, and also strong antinociceptive activity in writhing test. CME and FBE contain potent inhibitory activity on the chick embryo chorioallantoic membrane (CAM) angiogenesis in a dose-dependent manner. Cordycepin, a metabolite of Cordyceps militaris, appeared to be at least partly responsible for its anti-inflammatory and anti-angiogenic activities. CME concentration-dependently inhibited the NO production and iNOS expression upon stimulation by lipoposaccharide in RAW 264.7, a murine macrophage cell line. In brief, we demontrate that Cordyceps militaris possesses anti-inflammatory and antinociceptive activites, and related antioxidant, anti-angiogenic, and NO production-inhibitory activities.  相似文献   

18.
目的:观察虫草多糖对二甲基亚硝胺(DMN)诱导的大鼠肝纤维化的药理作用.方法:采用DMN大鼠肝纤维化模型,分为正常组(N,n=6)、模型组(M,n=11)、虫草多糖组(C,n=8)、秋水仙碱组(Q,n=9).造模4周,虫草多糖(60 mg·kg-1)和秋水仙碱(0.1 mg·kg-1)灌胃给药3周,模型与正常组国时给予等量灭菌水.观察血清ALT,AST,GGT活性及Alb,TBil含量;肝组织羟脯氨酸(Hyp)含量;肝脏病理及胶原染色;肝组织SOD活性及MDA,GSH,GSH-Px含量;肝脏组织增殖细胞核抗原(PCNA)蛋白表达.结果:模型组血清ALT,AST,GGT,TBil显著升高,Alb显著降低,虫草多糖组血清AST,TBil显著降低,Alb显著升高;模型组肝组织Hyp显著升高,虫草多糖、秋水仙碱组则显著降低;HE染色:模型组正常肝小叶结构破坏,肝细胞水肿,汇管区结缔组织增生,虫草多糖及秋水仙碱组上述病理变化显著减轻.胶原染色:模型组肝小叶纤维间隔形成,见较多完整假小叶;虫草多糖、秋水仙碱组胶原沉积减少.模型组肝组织SOD,GSH-Px,GSH显著降低,MDA显著增高,虫草多糖及秋水仙碱组GSH,GSH-Px活性显著增高.模型组肝组织PCNA蛋白表达显著升高,虫草多糖及秋水仙碱组则显著降低.结论:虫草多糖可显著抑制DMN诱导的大鼠肝纤维化及脂质过氧化损伤.  相似文献   

19.
Cordyceps sinensis is one of the most valued herbs in traditional Chinese medicine. We investigated the antioxidant activities of the cultured fruiting bodies of Cordyceps sinesis. The water and ethanol extracts of Cordyceps sinensis were found to possess a potent antioxidant activity. The scavenging effects of the extracts on superoxide were very weak, but the extracts moderately inhibited malondialdehyde formation via hydroxyl radical induced by SIN-1, a peroxynitrite generator. Of the extracts examined, the hot water extract (70 degrees C for 5 min) showed the greatest oxygen free radical scavenging activity. Also, when low-density lipoprotein (LDL) was incubated with macrophages in the presence of CuCl2 (1 microM), the hot water extract showed a strong inhibitory effect against lipid peroxidation in the medium and consequent accumulation of cholesteryl ester in macrophages. Their activities were comparable to that of authentic Cu/Zn SOD. These results suggest that the extracts of cultured Cordyceps sinensis possess potent antioxidant and anti-lipid peroxidation activities and inhibit accumulation of cholesteryl ester in macrophages via suppression of LDL oxidation.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号